Stock Analysis
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis
Tandem Diabetes Care, Inc. (TNDM) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Tandem Diabetes Care, Inc. (TNDM) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 64/100. Risk is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
TNDM at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $17.05 |
| AIQ Score | 55/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $1.4B |
| P/E Ratio (TTM) | -23.74 |
| Forward P/E | — |
| EPS (Q3 FY2026) | -$0.10 |
| Revenue (Q3 FY2026) | $283.69M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.07 |
| Volume | 2.35M |
| 52-week range | $12.26-$29.65 |
| RSI 14 | 59.69 |
| 50-Day SMA | $17.40 |
| 200-Day SMA | $18.84 |
| Analyst Price Target | $19.00 |
| Next Earnings | Feb 18, 2027 |
TNDMTandem Diabetes Care, Inc.
Healthcare / Medical - Devices
Low Priority
In Line With Peers
Latest quote
- Momentum59
- Value64
- Quality51
- Risk resilience38
- Sentiment—
TNDM Stock Analysis Summary
Tandem Diabetes Care, Inc. (TNDM) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 64/100. Risk resilience is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, TNDM has AIQ Score of 55/100 with Value base of 64/100 and fading Risk resilience at 38/100. Wait for component alignment before adding exposure.
Value (64/100) leads while Risk resilience (38/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.06% stock move · TNDM classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is TNDM Bullish or Bearish Right Now?
TNDM currently has a neutral overall setup. Value is the strongest factor at 64/100, while Risk Resilience is weakest at 38/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Price is +15.35% above its 50-day SMA.
- - Analyst target implies +11.44% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (38 vs 3).
- - Risk Resilience is weak at 38/100.
Current Consensus
TNDM's Technical Analysis Consensus is currently Strong Buy, with 38 buy, 5 neutral, and 3 sell votes. TNDM's 14-day RSI is 59.69, which places the stock in a constructive momentum range. TNDM's beta is 1.07, indicating market sensitivity broadly in line with the market.
What Changed in TNDM?
The largest recent change in TNDM is Momentum moving down by 2.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the TNDM Outlook?
The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
TNDM Decision Framework
Public evidence layers, setup checks, and risk context for Tandem Diabetes Care, Inc..
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis
Tandem Diabetes Care, Inc. has an AIQ Score of 55/100 in a Neutral regime. Value is strongest at 64/100. Beta is 1.07, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | TNDM is in a Neutral AIQ regime with score 55/100. |
| Signal Conflict | The primary conflict is that value leads at 64/100 while risk lags at 38/100. |
| Factor Evidence | Momentum 59/100 · Value 64/100 · Quality 51/100 · Risk 38/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 64/100.
Momentum is 59/100 and RSI (14) is 59.7.
TNDM is in a Neutral regime at 55/100.
Risk factor is 38/100 with beta 1.07 and annual volatility 75.74%.
Current conflict: value leads at 64/100 while risk lags at 38/100.
TNDM Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
TNDM Fundamentals
TNDM valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
TNDM Technical Analysis
TNDM technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
TNDM Stock Catalysts
Track TNDM earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
TNDM Dividend Analysis
TNDM dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
TNDM Financial Data
TNDM revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
TNDM Risk Analysis
TNDM volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
TNDM Stock News
TNDM stock news, market tone, recent headlines, and catalyst context.
TNDM vs Medical - Devices Peers
Current peer cohort: TNDM · UFPT · ATEC · AXGN · BBNX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| TNDM Current stock | 55/100 | 64/100 | 59/100 | 38/100 | 0.49 | 75.74% | Current |
| UFPT UFP Technologies, Inc. | 68/100 | 61/100 | 81/100 | 56/100 | 0.69 | 50.83% | TNDM vs UFPT |
| ATEC Alphatec Holdings, Inc. | 48/100 | 61/100 | 47/100 | 28/100 | -0.94 | 78.93% | TNDM vs ATEC |
| AXGN AxoGen, Inc. | 65/100 | 33/100 | 82/100 | 55/100 | 1.61 | 61.27% | TNDM vs AXGN |
| BBNX Beta Bionics, Inc. | 54/100 | 39/100 | 72/100 | 36/100 | -0.16 | 84.66% | TNDM vs BBNX |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for TNDM: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching TNDM
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for TNDM
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
TNDM Stock FAQ
What is TNDM stock price today?
Tandem Diabetes Care, Inc.'s current stock price is $17.05. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is TNDM bullish or bearish right now?
TNDM's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is TNDM's market cap?
TNDM's market cap is $1.4B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is TNDM's current P/E ratio?
TNDM's current P/E ratio is -23.74 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is TNDM's RSI?
TNDM's 14-day RSI is 59.69 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is TNDM above its 50-day and 200-day moving averages?
TNDM is 15.35% from its 50-day SMA and 6.54% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is TNDM's next earnings date?
TNDM's next earnings date is currently listed as Feb 18, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does TNDM pay a dividend?
TNDM's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.